Olig gene function in CNS development and disease

GLIA

Volumn 54, Issue 1, 2006, Pages 1-10

  Ligon, Keith L ^a,b   Fancy, Stephen P J ^c   Franklin, Robin J M ^c   Rowitch, David H ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Brain cancer; Cell fate; CNS development; Multiple sclerosis; Neural stem cell; Oligodendrocyte; Transcription factor

Indexed keywords

OLIGODENDROCYTE TRANSCRIPTION FACTOR 1; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

BRAIN TUMOR; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; DEMYELINATING DISEASE; GENE; GENE EXPRESSION; GENE FUNCTION; MOTONEURON; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NEURAL TUBE; NONHUMAN; OLIGODENDROCYTE TRANSCRIPTION FACTOR 1 GENE; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2 GENE; OLIGODENDROGLIA; PRIORITY JOURNAL; REVIEW; SPINAL CORD;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BRAIN NEOPLASMS; CELL DIFFERENTIATION; CELL LINEAGE; CENTRAL NERVOUS SYSTEM; DEMYELINATING DISEASES; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; NERVE TISSUE PROTEINS; OLIGODENDROGLIA; STEM CELLS;

EID: 33745576853     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20273     Document Type: Review

References (96)

1. Agius E, Soukkarieh C, Danesin C, Kan P, Takebayashi H, Soula C, Cochard P. 2004. Converse control of oligodendrocyte and astrocyte lineage development by Sonic hedgehog in the chick spinal cord. Dev Biol 270:308-321.
2. Aguirre AA, Chittajallu R, Belachew S, Gallo V. 2004. NG2-expressing cells in the subventricular zone are type C-like cells and contribute to interneuron generation in the postnatal hippocampus. J Cell Biol 165:575-589.
3. Alberta JA, Park SK, Mora J, Yuk D, Pawlitzky I, Iannarelli P, Vartanian T, Stiles CD, Rowitch DH. 2001. Sonic hedgehog is required during an early phase of oligodendrocyte development in mammalian brain. Mol Cell Neurosci 18:434-441.
4. Alvarez-Buylla A, Garcia-Verdugo JM, Tramontin AD. 2001. A unified hypothesis on the lineage of neural stem cells. Nat Rev Neurosci 2:287-293.
5. Arnett HA, Fancy SP, Alberta JA, Zhao C, Plant SR, Kaing S, Raine CS, Rowitch DH, Franklin RJM, Stiles CD. 2004. bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS. Science 306:2111-2115.
6. Azzarelli B, Miravalle L, Vidal R. 2004. Immunolocalization of the oligodendrocyte transcription factor 1 (Olig1) in brain tumors. J Neuropathol Exp Neurol 63:170-179.
7. Bachoo RM, Kim RS, Ligon KL, Maher EA, Brennan C, Billings N, Chan S, Li C, Rowitch DH, Wong WH, DePinho RA. 2004. Molecular diversity of astrocytes with implications for neurological disorders. Proc Natl Acad Sci USA 101:8384-8389.
8. Back SA, Rivkees SA. 2004. Emerging concepts in periventricular white matter injury. Semin Perinatol 28:405-414.
9. Bergles DE, Roberts JD, Somogyi P, Jahr CE. 2000. Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus. Nature 405:187-191.
10. Bjartmar C, Wujek JR, Trapp BD. 2003. Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J Neurol Sci 206:165-171.
11. Butt AM, Kiff J, Hubbard P, Berry M. 2002. Synantocytes: new functions for novel NG2 expressing glia. J Neurocytol 31:551-565.
12. Cai J, Qi Y, Hu X, Tan M, Liu Z, Zhang J, Li Q, Sander M, Qiu M. 2005. Generation of oligodendrocyte precursor cells from mouse dorsal spinal cord independent of Nkx6 regulation and Shh signaling. Neuron 45:41-53.
13. Campagnoni AT, Skoff RP. 2001. The pathobiology of myelin mutants reveal novel biological functions of the MBP and PLP genes. Brain Pathol 11:74-91.
14. Carpentier AF. 2005. Neuro-oncology: the growing role of chemotherapy in glioma. Lancet Neurol 4:4-5.
15. Chandran S, Kato H, Gerreli D, Compston A, Svendsen CN, Allen ND. 2003. FGF-dependent generation of oligodendrocytes by a hedgehog-independent pathway. Development 130:6599-6609.
16. Chang A, Nishiyama A, Peterson J, Prineas J, Trapp BD. 2000. NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J Neurosci 20:6404-6412.
17. Chang A, Tourtellotte WW, Rudick R, Trapp BD. 2002. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 346:165-173.
18. Chekenya M, Pilkington GJ. 2002. NG2 precursor cells in neoplasia: functional, histogenesis and therapeutic implications for malignant brain tumours. J Neurocytol 31:507-521.
19. Colman DR, Pedraza L, Yoshida M. 1996. In: Jessen KR, Richardson WD, editors. Glial cell development: basic principles and clinical relevance myelin sheath structure, function, and evolution. Oxford: BIOS Scientific Publishers; Distributors [for the] USA and Canada, Books International. The Molecular and cellular neurobiology series. p 85-98.
20. Compston A, Coles A. 2002. Multiple sclerosis. Lancet 359:1221-1231.
21. Dawson MR, Polito A, Levine JM, Reynolds R. 2003. NG2-expressing glial progenitor cells: an abundant and widespread population of cycling cells in the adult rat CNS. Mol Cell Neurosci 24:476-488.
22. Doetsch F. 2003. A niche for adult neural stem cells. Curr Opin Genet Dev 13:543-550.
23. Edgar JM, McLaughlin M, Yool D, Zhang SC, Fowler JH, Montague P, Barrie JA, McCulloch MC, Duncan ID, Garbern J, Nave KA, Griffiths IR. 2004. Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia. J Cell Biol 166:121-131.
24. Fancy SP, Zhao C, Franklin RJM. 2004. Increased expression of Nkx2.2 and Olig2 identifies reactive oligodendrocyte progenitor cells responding to demyelination in the adult CNS. Mol Cell Neurosci 27:247-254.
25. Ferrando AA, Neuberg DS, Dodge RK, Paietta E, Larson RA, Wiernik PH, Rowe JM, Caligiuri MA, Bloomfield CD, Look AT. 2004. Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia. Lancet 363:535-536.
26. ffrench-Constant C, Raff MC. 1986. The oligodendrocyte-type-2 astrocyte cell lineage is specialized for myelination. Nature 323:335-338.
27. Fogarty M, Richardson WD, Kessaris N. 2005. A subset of oligodendrocytes generated from radial glia in the dorsal spinal cord. Development 132:1951-1959.
28. Franklin RJM. 2002. Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci 3:705-714.
29. Franklin RJM, Goldman JE. 2004. Remyelination by endogenous glia. In: Lazzarini RA, editor. Myelin biology and disorders. San Diego, CA: Elsevier Academic Press. p 173-196.
30. Garbern JY, Yool DA, Moore GJ, Wilds IB, Faulk MW, Klugmann M, Nave KA, Sistermans EA, van der Knaap MS, Bird TD, Shy ME, Kamholz JA, Griffiths IR. 2002. Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. Brain 125(Pt 3):551-561.
31. Gray PA, Fu H, Luo P, Zhao Q, Yu J, Ferrari A, Tenzen T, Yuk DI, Tsung EF, Cai Z, Alberta JA, Cheng LP, Liu Y, Stenman JM, Valerius MT, Billings N, Kim HA, Greenberg ME, McMahon AP, Rowitch DH, Stiles CD, Ma Q. 2004. Mouse brain organization revealed through direct genome-scale TF expression analysis. Science 306:2255-2257.
32. Greenwood K, Butt AM. 2003. Evidence that perinatal and adult NG2-glia are not conventional oligodendrocyte progenitors and do not depend on axons for their survival. Mol Cell Neurosci 23:544-558.
33. Griffiths I, Klugmann M, Anderson T, Yool D, Thomson C, Schwab MH, Schneider A, Zimmermann F, McCulloch M, Nadon N, Nave KA. 1998. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 280:1610-1613.
34. Hack MA, Sugimori M, Lundberg C, Nakafuku M, Gotz M. 2004. Regionalization and fate specification in neurospheres: the role of Olig2 and Pax6. Mol Cell Neurosci 25:664-678.
35. Hack MA, Saghatelyan A, de Chevigny A, Pfeifer A, Ashery-Padan R, Lledo PM, Gotz M. 2005. Neuronal fate determinants of adult olfactory bulb neurogenesis. Nat Neurosci 8:865-872.
36. Hinks GL, Franklin RJM. 1999. Distinctive patterns of PDGF-A, FGF-2, IGF-I, and TGF-beta1 gene expression during remyelination of experimentally-induced spinal cord demyelination. Mol Cell Neurosci 14:153-168.
37. Hoang-Xuan K, Aguirre-Cruz L, Mokhtari K, Marie Y, Sanson M. 2002. OLIG-1 and 2 gene expression and oligodendroglial tumours. Neuropathol Appl Neurobiol 28:89-94.
38. Holland EC, Varmus HE. 1998. Basic fibroblast growth factor induces cell migration and proliferation after glia-specific gene transfer in mice. Proc Natl Acad Sci USA 95:1218-1223.
39. Horner PJ, Thallmair M, Gage FH. 2002. Defining the NG2-expressing cell of the adult CNS. J Neurocytol 31:469-480.
40. Inoue K, Khajavi M, Ohyama T, Hirabayashi S, Wilson J, Reggin JD, Mancias P, Butler IJ, Wilkinson MF, Wegner M, Lupski JR. 2004. Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations. Nat Genet 36:361-369.
41. Inoue K, Tanabe Y, Lupski JR. 1999. Myelin deficiencies in both the central and the peripheral nervous systems associated with a SOX10 mutation. Ann Neurol 46:313-318.
42. Jessell TM. 2000. Neuronal specification in the spinal cord: inductive signals and transcriptional codes. Nat Rev Genet 1:20-29.
43. Jones LL, Yamaguchi Y, Stallcup WB, Tuszynski MH. 2002. NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors. J Neurosci 22:2792-2803.
44. Kessaris N, Pringle N, Richardson WD. 2001. Ventral neurogenesis and the neuron-glial switch. Neuron 31:677-680.
45. Kinney HC, Back SA. 1998. Human oligodendroglial development: relationship to periventricular leukomalacia. Semin Pediatr Neurol 5: 180-189.
46. Kornek B, Storch MK, Weissert R, Wallström E, Stefferl A, Olsson T, Linington C, Schmidbauer M, Lassmann H. 2000. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol 157:267-276.
47. Lappe-Siefke C, Goebbels S, Gravel M, Nicksch E, Lee J, Braun PE, Griffiths IR, Nave KA. 2003. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat Genet 33: 366-374.
48. Levine JM, Card JP. 1987. Light and electron microscopic localization of a cell surface antigen (NG2) in the rat cerebellum: association with smooth protoplasmic astrocytes. J Neurosci 7:2711-2720.
49. Levine JM, Reynolds R, Fawcett JW. 2001. The oligodendrocyte precursor cell in health and disease. Trends Neurosci 24:39-47.
50. Ligon KL, Alberta JA, Kho AT, Weiss J, Kwaan MR, Nutt CL, Louis DN, Stiles CD, Rowitch DH. 2004. The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas. J Neuropathol Exp Neurol 63:499-509.
51. Ligon KL, Kesari S, Kitada M, Sun T, Arnett HA, Alberta JA, Anderson DJ, Stiles CD, Rowitch DH. 2006. Development of NG2 progenitor cells requires Olig gene function. Proc Natl Acad Sci (in press).
52. Lin SC, Bergles DE. 2002. Physiological characteristics of NG2-expressing glial cells. J Neurocytol 31:537-549.
53. Liu Y, Rao MS. 2004. Olig genes are expressed in a heterogeneous population of precursor cells in the developing spinal cord. Glia 45:67-74.
54. Louis DN, Pomeroy SL, Cairncross JG. 2002. Focus on central nervous system neoplasia. Cancer Cell 1:125-128.
55. Lu QR, Yuk D, Alberta JA, Zhu Z, Pawlitzky I, Chan J, McMahon AP, Stiles CD, Rowitch DH. 2000. Sonic hedgehog-regulated oligodendrocyte lineage genes encoding bHLH proteins in the mammalian central nervous system. Neuron 25:317-329.
56. Lu QR, Cai L, Rowitch D, Cepko CL, Stiles CD. 2001. Ectopic expression of Olig1 promotes oligodendrocyte formation and reduces neuronal survival in developing mouse cortex. Nat Neurosci 4:973-974.
57. Lu QR, Sun T, Zhu Z, Ma N, Garcia M, Stiles CD, Rowitch DH. 2002. Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection. Cell 109:75-86.
58. Mao X, Fujiwara Y, Chapdelaine A, Yang H, Orkin SH. 2001. Activation of EGFP expression by Cre-mediated excision in a new ROSA26 reporter mouse strain. Blood 97:324-326.
59. Marie Y, Sanson M, Mokhtari K, Leuraud P, Kujas M, Delattre JY, Poirier J, Zalc B, Hoang-Xuan K. 2001. OLIG2 as a specific marker of oligodendroglial tumour cells. Lancet 358:298-300.
60. Marquardt T, Pfaff SL. 2001. Cracking the transcriptional code for cell specification in the neural tube. Cell 106:651-654.
61. Marshall CA, Suzuki SO, Goldman JE. 2003. Gliogenic and neurogenic progenitors of the subventricular zone: who are they, where did they come from, and where are they going? Glia 43:52-61.
62. Mimault C, Giraud G, Courtois V, Cailloux F, Boire JY, Dastugue B, Boespflug-Tanguy O. 1999. Proteolipoprotein gene analysis in 82 patients with sporadic Pelizaeus-Merzbacher disease: duplications, the major cause of the disease, originate more frequently in male germ cells, but point mutations do not. The Clinical European Network on Brain Dysmyelinating Disease. Am J Hum Genet 65:360-369.
63. Mizuguchi R, Sugimori M, Takebayashi H, Kosako H, Nagao M, Yoshida S, Nabeshima Y, Shimamura K, Nakafuku M. 2001. Combinatorial roles of olig2 and neurogenin2 in the coordinated induction of pan-neuronal and subtype-specific properties of motoneurons. Neuron 31:757-771.
64. Mokhtari K, Paris S, Aguirre-Cruz L, Privat N, Criniere E, Marie Y, Hauw JJ, Kujas M, Rowitch D, Hoang-Xuan K, Delattre JY, Sanson M. 2005. Olig2 expression, GFAP, p53 and 1p loss analysis contribute to glioma subclassification. Neuropathol Appl Neurobiol 31:62-69.
65. iP on oligodendrocyte development. Dev Biol 265:33-52.
66. Novitch BG, Chen AI, Jessell TM. 2001. Coordinate regulation of motor neuron subtype identity and pan-neuronal properties by the bHLH repressor Olig2. Neuron 31:773-789.
67. Ohnishi A, Sawa H, Tsuda M, Sawamura Y, Itoh T, Iwasaki Y, Nagashima K 2003. Expression of the oligodendroglial lineage-associated markers Olig1 and Olig2 in different types of human gliomas. J Neuropathol Exp Neurol 62:1052-1059.
68. Orentas DM, Hayes JE, Dyer KL, Miller EH. 1999. Sonic hedgehog signaling is required during the appearance of spinal cord oligodendrocyte precursors. Development 126:2419-2429.
69. Rao MS, Mayer-Proschel M. 1997. Glial-restricted precursors are derived from multipotent neuroepithelial stem cells. Dev Biol 188:48-63.
70. Rowitch DH. 2004. Glial specification in the vertebrate neural tube. Nat Rev Neurosci 5:409-419.
71. Rowitch DH, Lu QR, Kessaris N, Richardson WD. 2002. An "oligarchy" rules neural development. Trends Neurosci 25:417-422.
72. Schneider A, Montague P, Griffiths I, Fanarraga M, Kennedy P, Brophy P, Nave KA. 1993. Uncoupling of hypomyelination and glial cell death by a mutation in the proteolipid protein gene. Nature 358:758-761.
73. Scolding N, Franklin RJM, Stevens S, Heldin CH, Compston A, Newcombe J. 1998. Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis. Brain 121(Pt 12):2221-2228.
74. Setoguchi T, Kondo T. 2004. Nuclear export of OLIG2 in neural stem cells is essential for ciliary neurotrophic factor-induced astrocyte differentiation. J Cell Biol 166:963-968.
75. Shimizu T, Kagawa T, Wada T, Muroyama Y, Takada S, Ikenaka K. 2005. Wnt signaling controls the timing of oligodendrocyte development in the spinal cord. Dev Biol 282:397-410.
76. Soula C, Danesin C, Kan P, Grob M, Poncet C, Cochard P. 2001. Distinct sites of origin of oligodendrocytes and somatic motoneurons in the chick spinal cord: oligodendrocytes arise from Nkx2.2-expressing progenitors by a Shh-dependent mechanism. Development 128:1369-1379.
77. Sun T, Dong H, Wu L, Kane M, Rowitch DH, Stiles CD. 2003. Cross-repressive interaction of the Olig2 and Nkx2.2 transcription factors in developing neural tube associated with formation of a specific physical complex. J Neurosci 23:9547-9556.
78. Suzuki SO, Goldman JE. 2003. Multiple cell populations in the early postnatal subventricular zone take distinct migratory pathways: a dynamic study of glial and neuronal progenitor migration. J Neurosci 23:4240-4250.
79. Takebayashi H, Ohtsuki T, Uchida T, Kawamoto S, Okubo K, Ikenaka K, Takeichi M, Chisaka O, Nabeshima Y. 2002. Non-overlapping expression of Olig3 and Olig2 in the embryonic neural tube. Mech Dev 113:169-174.
80. Takebayashi H, Yoshida S, Sugimori M, Kosako H, Kominami R, Nakafuku M, Nabeshima Y. 2000. Dynamic expression of basic helix-loop-helix Olig family members: implication of Olig2 in neuron and oligodendrocyte differentiation and identification of a new member, Olig3. Mech Dev 99:143-148.
81. + oligodendrocyte precursor cells fail to remyelinate the demyelinated adult rat spinal cord in the absence of astrocytes. Exp Neurol 192:11-24.
82. Touraine RL, Attie-Bitach T, Manceau E, Korsch E, Sarda P, Pingault V, Encha-Razavi F, Pelet A, Auge J, Nivelon-Chevallier A, Holschncider AM, Munnes M, Doerfler W, Goossens M, Munnich A, Vekemans M, Lyonnet S. 2000. Neurological phenotype in Waardenburg syndrome type 4 correlates with novel SOX10 truncating mutations and expression in developing brain. Am J Hum Genet 66:1496-1503.
83. Vallstedt A, Muhr J, Pattyn A, Pierani A, Mendelsohn M, Sander M, Jessell TM, Ericson J. 2001. Different levels of repressor activity assign redundant and specific roles to Nkx6 genes in motor neuron and interneuron specification. Neuron 31:743-755.
84. Vallstedt A, Klos JM, Ericson J. 2005. Multiple dorsoventral origins of oligodendrocyte generation in the spinal cord and hindbrain. Neuron 45:55-67.
85. Volpe JJ. 2001. Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res 50:553-562.
86. Watanabe M, Hadzic T, Nishiyama A. 2004. Transient upregulation of Nkx2.2 expression in oligodendrocyte lineage cells during remyelination. Glia 46:311-322.
87. Wolswijk G. 1998. Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J Neurosci 18:601-609.
88. Wolswijk G, Noble M. 1989. Identification of an adult-specific glial progenitor cell. Development 105:387-400.
89. Woodruff RH, Franklin RJM. 1999. Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide, and complement/antigalactocerebroside: a comparative study. Glia 25:216-228.
90. Xin M, Yue T, Ma Z, Wu FF, Gow A, Lu QR. 2005. Myelinogenesis and axonal recognition by oligodendrocytes in brain are uncoupled in Olig1-null mice. J Neurosci 25:1354-1365.
91. + cells. J Neurosci 23:4401-4405.
92. Yoon BH, Park CW, Chaiworapongsa T. 2003. Intrauterine infection and the development of cerebral palsy. Br J Obstet Gynaecol 110(suppl 20):124-127.
93. Zalc B, Colman DR. 2000. Origins of vertebrate success. Science 288: 271-272.
94. Zhou Q, Anderson DJ. 2002. The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification. Cell 109:61-73.
95. Zhou Q, Wang S, Anderson DJ. 2000. Identification of a novel family of oligodendrocyte lineage-specific basic helix-loop-helix transcription factors. Neuron 25:331-343.
96. Zhou Q, Choi G, Anderson DJ. 2001. The bHLH transcription factor Olig2 promotes oligodendrocyte differentiation in collaboration with Nkx2.2. Neuron 31:791-307.